SESSION TITLE: Pulmonary Vascular Disease II
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Pulmonary arterial hypertension (PAH) is a well-known complication in patients with systemic sclerosis (SSc), harbouring a bad prognosis. While the diagnosis is confirmed by right heart catheterisation (RHC), the initial suspicion of PAH and follow-up measurements rely on non-invasive diagnostic tools. Pathophysiological considerations suggest that cardiopulmonary exercise testing (CPET) may provide clinical information on the mechanism of exercise limitation in SSc patients, and reflect the course of the disease during follow-up. However, the prognostic relevance of exercise gas exchange measurements during follow-up of SSc patients is unclear. We analyzed whether CPET provided relevant prognostic information in the long-term follow up of SSc patients.